CN Patent
CN101113148A — 二氧哌嗪类化合物及其制备方法和用途
Assigned to CHINA OCEAN MINERAL RESOURCES R&D ASSOCIATION · Expires 2008-01-30 · 18y expired
What this patent protects
本发明涉及两种二氧哌嗪类化合物的制备方法和用途。本发明用采自福建红树林根际海泥中的疏展曲霉菌H1-1(Aspergillus effuses H1-1)生产出结构新颖的二氧哌嗪类化合物。经实验证实,该类化合物可作为细胞增殖抑制剂或抗肿瘤剂。
USPTO Abstract
本发明涉及两种二氧哌嗪类化合物的制备方法和用途。本发明用采自福建红树林根际海泥中的疏展曲霉菌H1-1(Aspergillus effuses H1-1)生产出结构新颖的二氧哌嗪类化合物。经实验证实,该类化合物可作为细胞增殖抑制剂或抗肿瘤剂。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.